POPNIL-D
Description
- Combines Pantoprazole (PPI) and Domperidone (prokinetic)
- Treats GERD, dyspepsia, acid reflux, and associated nausea
- Reduces stomach acid production and enhances gastric motility
- Provides relief from bloating, heaviness, and indigestion
- Promotes healing of acid-damaged gastric mucosa
- Ideal for patients with reflux-related nausea or vomiting
- Convenient and effective combination therapy for GI disorders
Composition
PENTOPRAZOLE-20 MG, DOMPERIDONE-10 MG,
Benefits
POPNIL-D provides effective symptom relief for patients suffering from GERD, heartburn, indigestion, and acid-related nausea. Pantoprazole ensures long-lasting acid suppression, aiding the healing of the stomach lining and esophagus. Domperidone improves gastric emptying, reducing feelings of fullness and bloating. This combination is ideal for individuals with coexisting symptoms of acid reflux and delayed gastric motility, offering fast relief and improved digestive comfort with once or twice daily use, as directed by a physician.
Introduction
POPNIL-D is a combination medication containing Pantoprazole 20 mg, a proton pump inhibitor (PPI), and Domperidone 10 mg, a prokinetic agent. This dual-action formula is designed to provide rapid and sustained relief from acid reflux, gastroesophageal reflux disease (GERD), bloating, and nausea. Pantoprazole reduces the production of stomach acid, while Domperidone enhances gastrointestinal motility and prevents nausea and vomiting by acting on the brain’s dopamine receptors. Together, they offer comprehensive management of upper gastrointestinal disorders.
